Change in the Sobi Board of Directors
STOCKHOLM, Oct. 21, 2025 /PRNewswire/ — Sobi® (STO: SOBI), a global biopharmaceutical company today announced that Helena Saxon a member of the Sobi board... Read more.
PleoPharma, Inc. Closes $36 Million Series B Financing Round
Financing led by Biotech Specialist Funds and a Generalist with significant participation from Series A investors Proceeds will support the Phase 3 Program for... Read more.
XNRGY Secures Investment from BlackRock- and Temasek-Backed Decarbonization Partners, Climate Investment and Activate Capital to Accelerate Expansion of Sustainable Cooling Technologies
MESA, Ariz. and MONTREAL, Oct. 21, 2025 /PRNewswire/ – XNRGY Climate Systems, a leading North American manufacturer of sustainable liquid and air-cooling technologies... Read more.
Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting
Company to Spotlight Comprehensive Hip & Knee Portfolios and Latest Advancements in Robotics, Including the mBôs™ System Following Recent Acquisition of Monogram... Read more.
Lockheed Martin Reports Third Quarter 2025 Financial Results
Sales of $18.6 billion Net earnings of $1.6 billion, or $6.95 per share Cash from operations of $3.7 billion and free cash flow of $3.3 billion Returned $1.8 billion... Read more.
From Dallas to Toronto: FlixBus Connects All Host Cities for the World’s Biggest Soccer Tournament in 2026
Intercity bus travel makes it easy and affordable for fans to get to matches across the U.S., Canada, and Mexico DALLAS, Oct. 21, 2025 /PRNewswire/ — As millions... Read more.
Incline Closes Oversubscribed Continuation Vehicle for Accredited Labs
PITTSBURGH, Oct. 21, 2025 /PRNewswire/ — Incline Equity Partners (“Incline”), a leading private equity firm dedicated to investing across the middle... Read more.
Viking Therapeutics Announces Initiation of VK2735 Maintenance Dosing Clinical Trial in Patients with Obesity
Study to Explore Maintenance Dosing Regimens Following Initial Weight Loss with VK2735 Monthly Subcutaneous, Weekly Oral, and Daily Oral Regimens to be Evaluated... Read more.
Subtle Medical Announces Positive Findings from Proof-of-Concept Study with Bayer Investigating AI To Lower Gadolinium Dose in CE-MRI
MENLO PARK, Calif., Oct. 21, 2025 /PRNewswire/ — Subtle Medical, Inc., a leader in AI-powered medical imaging solutions, today announced positive findings... Read more.
Q32 Bio Announces Completion of Enrollment in Part B of SIGNAL-AA Phase 2a Clinical Trial of Bempikibart for Alopecia Areata
— SIGNAL-AA Part B exceeded target enrollment based on demand from patients; trial size increased to 33 patients — WALTHAM, Mass., Oct. 21, 2025 /PRNewswire/... Read more.